References

1. 1.
   China Hypertension Prevention Guideline Revision Committee，Hypertension Alliance ，Hypertension Branch of China Association for International Exchange and Promotion of Health Care，et al.Guidelines for the prevention and treatment of hypertension in China（2024 revised edition）［J］.Chin J Hyp，2024，32（7）：603-700.
2. 2.
   MA L Y，WANG Z W，FAN J，et al.Interpretation of the key points of China Cardiovascular Health and Disease Report 2022［J］.Chin Gener Prac，2023，26（32）：3975-3994.
3. 3.
   XU Q，WANG W T，LI Y W，et al.Relationship between gut microbiota dysbiosis and cardiometabolic diseases based on "heart-spleen-intestine" axis［J］.Chin J Exp Tradit Med Form，2024，30（20）：203-211.
4. 4.
   Health Management Branch of Chinese Medical Association，Editorial Committee of Chinese Journal of Health Management，National Geriatric Clinical Research Center.Expert consensus on health education for prevention and control of adult metabolic syndrome［J］.Chin J Health Manag，2024，18（2）：81-92.
5. 5.
   Compilation Group of Clinical Guidelines for the Prevention and Treatment of Type 2 diabetes in the Elderly in China，Endocrine and Metabolic Society for the Elderly of China Geriatrics Society，Endocrine and Metabolic Society for the Elderly of China Geriatrics Healthcare Research Society，et al.Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China （2022 edition）［J］.Chin J Intern Med，2022，61（1）：12-50.
6. 6.
   ZHANG Y，LI Y，ZHENG Z Y，et al.Treatment of cardiovascular diseases in diabetes mellitus withtraditional Chinese medicine：A review［J］.Chin J Exp Tradit Med Form，2024，30（23）：327-337.
7. 7.
   中华医学会糖尿病学分会.中国2型糖尿病防治指南（2020年版）（下）［J］.中国实用内科杂志，2021，41（9）：757-784.
8. 8.
   WEI Z X，XIA C D，LI H L，et al.TCM diagnosis and treatment standard of diabetes mellitus complicated with metabolic syndrome［J］.World J Integr Med，2011，6（2）：177-179.
9. 9.
   TONG X L，LIU X M，WEI J P，et al.Guide for diabetes prevention and control of traditional Chinese medicine［J］.Chin Med Mod Dist Edu China，2011，9（4）：148-151.
10. 10.
    National Health Commission，State Administration of Traditional Chinese Medicine.Clinical diagnosis and treatment of traditional Chinese medicine Part 2：Syndromes［M］.Beijing：China Press of Chinese Medicine，2021：416.
11. 11.
    Department of Medical Administration，State Administration of Traditional Chinese Medicine.Traditional Chinese medicine diagnosis and treatment plan of 95 diseases in 22 majors［M］.Beijing ：Department of Medical Administration of the State Administration of Traditional Chinese Medicine，2010：213-217.
12. 12.
    GUAN M D，WANG Q F，YANG Y F，et al.Mechanism of vascular inflammation injury in metabolic syndrome and research progress of traditional Chinese medicine［J］.J Liaoning Univ Tradit Chin Med，2023，25（10）：163-167.
13. 13.
    Experts Consensus Group on Home-based Cardiac Rehabilitation in China.Chinese expert consensus on home-based rehabilitation for patients with cardiovascular disease［J］.Chin Circul J，2022，37（2）：108-121.
14. 14.
    ZHAO Y K，LI X F，YU L，et al.Research progress of berberine regulating inflammation in the treatment of cardiovascular diseases［J/OL］.Pharmacol Clin Chin Mater Med，2024..
15. 15.
    LUO C，ZHU C Y，PAN Y P，et al.Protective effect of Pinellia ternata polysaccharide on lipopolysaccharide-induced injury of human pulmonary microvascular endothelial cells［J］.Chin J Pharmacol Toxicol，2018，32（6）：455-461.
16. 16.
    ZHAO H，LIU M，LIU H，et al.Naringin protects endothelial cells from apoptosis and inflammation by regulating the Hippo-YAP Pathway［J］.Biosci Rep，2020，40（3）：BSR20193431.
17. 17.
    WANG Q，ZHAO M J，DONG J，et al.Poria cocos polysaccharide alleviates tissue damage in rats with myocardial infarction through NF-κB pathway［J］.Chongqing Med，2022，51（19）：3247-3252.
18. 18.
    TAO Q，LI J Y.Research progress on the relationship between inflammation and disease［J］.J Tradit Chin Veterin Med，2023，42（5）：34-43.
19. 19.
    LUQUE O F，MARTÍNEZ C A，IRIGOYEN A M，et al.LEP （G2548A-G19A） and ADIPOQ （T45G-G276T） gene polymorphisms are associated with markers for metabolic syndrome［J］.Diabetol Metab Syndr，2023，15（1）：237-237.
20. 20.
    WANG C H，WANG M，LIU H L，et al.Research progress on the correlation between leptin and metabolic syndrome［J］.Contempor Med Theor Ser，2019，17（13）：35-37.
21. 21.
    CHE K X，LU M Y，QIU J Q.Aerobic exercise prevents obesity-related insulin resistance：From the perspective of targeted inflammation［J］.Preven Ctrl Chr Dis China，2024，32（10）：790-795.
22. 22.
    CHEN Z C，LIN Q N，YANG Y F，et al.The role of pyroptosis in diabetes and its complications and the progress of traditional Chinese medicine intervention［J］.Chin Med Herb，2024，55（20）：7180-7191.
23. 23.
    LIU L，XU F R，LU Y.Effect of Modified Huanglian Wendan decoction on tumor necrosis factor-α and interleukin-6 in metabolic syndrome rats［J］.J Hubei Univ Chin Med，2012，14（3）：11-13.
24. 24.
    LI X L，WENY.Research overview of adiponectin［J］.J Pharmacoepidemiol，2011，20（10）：547-551.
25. 25.
    ZHANG Y M，YU G X，WANG C，et al.Research progress on pathogenesis and prevention of premature coronary heart disease［J］.Chin Clin Med，2024，31（3）：491-498.
26. 26.
    ZHEN X D，LIU K J，SHAO M M，et al.Clinical study of insulin resistance alternative indicators in patients with non-diabetic premature coronary heart disease［J］.Med Theor Pract，2024，37（16）：2706-2710，2735.
27. 27.
    WANG Y，WANG A H，TIAN T.The correlation between the levels of endothelin-1，adiponectin，C-reactive protein and related metabolic indexes in type 2 diabetes mellitus complicated with atherosclerosis［J］.Guangdong Med J，2019，40（7）：1020-1024.
28. 28.
    LIU Z Y，XU Q，TANG Y X，et al.Research progress on the regulation of endothelial nitric oxide synthase activity and cardiovascular diseases［J］.J Centr South Univ（Med Edi），2016，41（6）：632-636.